Table 2 treatment and response of HBs associated to prognoses
Variables | Results | 3-year RFS rate | P | |
|---|---|---|---|---|
AFP decreased after neoadjuvant chemotherapy (n, %) | 0.005 | |||
< 60% | 26 (46) | 28% | ||
≥ 60% | 30 (54) | 68% | ||
Evaluation criteria of WHO (n, %) | 0.004 | |||
CR | 0 | |||
PR | 32 (57) | 65.6% | ||
SD | 24 (43) | 29.2% | ||
PD | 0 | |||
POSTTEXT (n, %) | 0.476 | |||
I | 9 (16) | 66.7% | ||
II | 30 (54) | 50.0% | ||
III | 17 (30) | 41.1% | ||
IV | 0 | |||
Surgical strategy (n, %) | 0.747 | |||
Left lobectomy | 14 (25) | 42.9% | ||
Right lobectomy | 33 (59) | 54.6% | ||
Extended hepatectomy | 9 (16) | 44.4% | ||
AFP fell to normal (n, %) | 0.0005 | |||
< 6 months | 27 (48) | 68.6% | ||
≥ 6 months | 29 (52) | 50.0% |